Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction Market outline PART 05: Market landscape Market size and forecast Five forces analysis PART 06: Market segmentation by product Global epigenetics market by product Global epigenetics market by reagents Global epigenetics market by kits Global epigenetics market by others PART 07: Geographical segmentation Global epigenetics market by geography Epigenetics market in Americas Epigenetics market in EMEA Epigenetics market in APAC PART 08: Decision framework PART 09: Drivers and challenges Market drivers Market challenges PART 10: Market trends Increasing use of epigenetics as a tool to understand development and disease Increasing demand for personalized medicine Rise in investment in R&D PART 11: Vendor landscape Competitive scenario Investment opportunity analysis PART 12: Key vendor analysis Abcam Bio-Rad Laboratories Merck Thermo Fisher Scientific Other prominent vendors PART 13: Appendix List of abbreviations List of Exhibits Exhibit 01: Epigenetic changes in DNA Exhibit 02: Normal cellular functions regulated by epigenetic mechanisms and molecular abnormalities caused by epigenetic errors Exhibit 03: Global epigenetics market: Market overview Exhibit 04: Global epigenetics market 2016-2021 ($ billions) Exhibit 05: Factors impacting global epigenetics market Exhibit 06: Five forces analysis Exhibit 07: Global epigenetics market by product 2016-2021 (% share) Exhibit 08: Global epigenetics market by product: Snapshot Exhibit 09: Global epigenetics market by reagents 2016-2021 ($ billions) Exhibit 10: Global epigenetic market by kits 2016-2021 ($ billions) Exhibit 11: Global epigenetic market by others 2016-2021 ($ billions) Exhibit 12: Global epigenetics market by geography 2016-2021 (% share) Exhibit 13: Global epigenetics market by geography: Snapshot Exhibit 14: Epigenetics market in Americas 2016-2021 ($ billions) Exhibit 15: Epigenetics market in EMEA 2016-2021 ($ billions) Exhibit 16: Epigenetics market in APAC 2016-2021 ($ billions) Exhibit 17: Competitive parameters in global epigenetics market Exhibit 18: Investment opportunity mapping Exhibit 19: Strategic success factors for companies Exhibit 20: Abcam: Company profile Exhibit 21: Abcam: Strength analysis Exhibit 22: Abcam: Strategy assessment Exhibit 23: Abcam: Opportunity assessment Exhibit 24: Bio-Rad Laboratories: Company profile Exhibit 25: Bio-Rad Laboratories: Strength analysis Exhibit 26: Bio-Rad Laboratories: Strategy assessment Exhibit 27: Bio-Rad Laboratories: Opportunity assessment Exhibit 28: Merck: Company profile Exhibit 29: Merck: Strength analysis Exhibit 30: Merck: Strategy assessment Exhibit 31: Merck: Opportunity assessment Exhibit 32: Thermo Fisher Scientific: Company profile Exhibit 33: Thermo Fisher Scientific: Strength analysis Exhibit 34: Thermo Fisher Scientific: Strategy assessment Exhibit 35: Thermo Fisher Scientific: Opportunity assessment

Abcam, Bio-Rad Laboratories, Merck, Thermo Fisher Scientific, Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.